Suchergebnisse - "Courjon, Johan"

PubPharm (28)

1

Cardiac Adverse Events and Remdesivir in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19) : A Post Hoc Safety Analysis of the Randomized DisCoVeRy Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Terzić, V. | Miantezila Basilua, J. | Billard, N. | +123

2

Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy) : A phase 3, randomized, double-blind, placebo-controlled trial

enthalten in: The Journal of infection | 2024

von Hites, M. | Lapique, E. | Massonnaud, C. | +84

3

Lesson from the COVID-19 pandemic lockdown : A major change of hospital-diagnosed bacteremia epidemiology

enthalten in: Infectious diseases now | 2023

von Cauhapé, V. | Lamy, B. | Lotte, R. | +7

4

Accurate Detection of SARS-CoV-2 by Next-Generation Sequencing in Low Viral Load Specimens

enthalten in: International journal of molecular sciences | 2023

von Ilié, M. | Benzaquen, J. | Hofman, V. | +18

5

Breakthrough infections due to SARS-CoV-2 Delta variant : relation to humoral and cellular vaccine responses

enthalten in: Frontiers in immunology | 2023

von Buscot, M. | Cremoni, M. | Graça, D. | +9

6

Avdoralimab (Anti-C5aR1 mAb) Versus Placebo in Patients With Severe COVID-19 : Results From a Randomized Controlled Trial (FOR COVID Elimination [FORCE])

enthalten in: Critical care medicine | 2022

von Carvelli, J. | Meziani, F. | Dellamonica, J. | +124

CommentIn: Crit Care Med. 2022 Dec 1;50(12):1840-1842. - PMID 36394404

7

Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19

enthalten in: The Lancet. Infectious diseases | 2022

von Ader, F. | Bouscambert-Duchamp, M. | Hites, M. | +104

8

An open-label randomized, controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19 – Final results from the DisCoVeRy trial

enthalten in: bioRxiv.org | 2022

von Ader, F. | Peiffer-Smadja, N. | Poissy, J. | +55

9

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy) : a phase 3, randomised, controlled, open-label trial

enthalten in: The Lancet. Infectious diseases | 2022

von Ader, F. | Bouscambert-Duchamp, M. | Hites, M. | +115

CommentIn: Lancet Infect Dis. 2021 Sep 14;:null. - PMID 34534513

10

Efficacy and safety of anakinra in adults presenting deteriorating respiratory symptoms from COVID-19 : A randomized controlled trial

enthalten in: PloS one | 2022

von Audemard-Verger, A. | Le Gouge, A. | Pestre, V. | +27